StockData
Dermata Therapeutics, Inc. logo

Dermata Therapeutics, Inc. (DRMA) income statement

DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.51−0.02 (-4.23%)

Close on Nov 20, 2026Market cap $2.05MP/E –Yield –

See a number that looks wrong?